Show simple item record

AuthorZhu, Ziyudc.contributor.author
Date of accession2021-03-02T10:40:20Zdc.date.accessioned
Available in OPARU since2021-03-02T10:40:20Zdc.date.available
Year of creation2019dc.date.created
Date of first publication2021-03-02dc.date.issued
AbstractClostridium difficile (C. difficile) produces three toxins, namely the binary Clostridium difficile transferase (CDT) and the large single-chain toxins Clostridium difficile toxin A (TcdA) and Clostridium difficile toxin B (TcdB). Among which, TcdA and TcdB are the main etiological factors causing the Clostridium difficile associated diseases (CDADs), with the severe symptoms such as pseudomembranous colitis (PMC) or inflammatory bowel disease (IBD). Nowadays, Clostridium difficile infection (CDI) is considered one of the most urgent threats to public health worldwide, particularly relevant in Western countries. Although there are some regular antibiotics (metronidazole, vancomycine and fidaxomycine and so on) available to treat or prevent the CDI, the usage of the antibiotics helps many strains to resist towards these therapies contrarily. Actually, research has demonstrated that the main problem of the disease are the toxins, which are not targeted by the antibiotics so far. Therefore, it is urgent to develop the efficient novel therapeutic options against CDI, including pharmacological toxin inhibitors. This current research project, which exactly deals with this topic, was inspired by the observation in the Barth group. It is observed that bacitracin prevents the intoxication of mammalian cells with various AB-type protein toxins through inhibiting the translocation process of the enzyme subunit of the toxins into the cytosol of target cells. The bacitracin used in this project is produced by Bacillus subtilis as a polypeptide antibiotic, which is the mixture of closely related compounds. It has antibacterial activity against Gram-positive bacteria. The efficient neutralizing activity of bacitracin towards TcdA/TcdB was surprising and proved as the foundation for the future clinically relevant research. The results of this thesis suggest that, bacitracin has no effect on the enzyme activity of TcdA/TcdB but specifically blocks the transportation process of the enzyme subunits into the target cells cytosol. Bacitracin protects human intestinal cells and organoids with slightly low doses following a concentration-dependent manner, and has no adverse effects by its own. This makes bacitracin a highly attractive candidate to develop the novel therapeutic options against CDI and CDADs, as it inhibits the combination of TcdA and TcdB, and also neutralizes the third toxin CDT.dc.description.abstract
Languageendc.language.iso
PublisherUniversität Ulmdc.publisher
LicenseStandarddc.rights
Link to license texthttps://oparu.uni-ulm.de/xmlui/license_v3dc.rights.uri
KeywordClostridium difficile toxinsdc.subject
KeywordHuman organoidsdc.subject
Dewey Decimal GroupDDC 610 / Medicine & healthdc.subject.ddc
MeSHBacitracindc.subject.mesh
MeSHClostridioides difficiledc.subject.mesh
MeSHOrganoidsdc.subject.mesh
TitleBacitracin reduces the cytotoxic effects of Clostridium difficile toxins A and B on mammalian cells and human intestinal organoidsdc.title
Resource typeDissertationdc.type
Date of acceptance2021-01-27dcterms.dateAccepted
RefereeBarth, Holgerdc.contributor.referee
RefereeFrick, Manfreddc.contributor.referee
DOIhttp://dx.doi.org/10.18725/OPARU-35569dc.identifier.doi
PPN1750205726dc.identifier.ppn
URNhttp://nbn-resolving.de/urn:nbn:de:bsz:289-oparu-35631-8dc.identifier.urn
GNDBacitracindc.subject.gnd
GNDClostridium difficiledc.subject.gnd
GNDOrganoiddc.subject.gnd
FacultyMedizinische Fakultätuulm.affiliationGeneral
InstitutionUKU. Institut für Pharmakologie und Toxikologieuulm.affiliationSpecific
InstitutionInstitut für Allgemeine Physiologieuulm.affiliationSpecific
Grantor of degreeMedizinische Fakultätuulm.thesisGrantor
DCMI TypeTextuulm.typeDCMI
CategoryPublikationenuulm.category
Bibliographyuulmuulm.bibliographie


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record